Netherlands Neurology Devices Market Outlook 2031:
The Netherlands neurology devices market size was valued at USD 33 Million in 2022 and is projected to reach USD 48.62 Million by 2031, expanding at a CAGR of 4.4% during the forecast period 2023 - 2031. The growth of the market is attributed to the increasing incidents of neurology disorders.
Neurological devices help to restore hearing and sight and provide increased function for individuals with congenital limb differences. It deals with disorder of the nervous system, which majorly comprise in brain, blood vessels, and muscles. More than 600 neurological disorders have been found in humans, which includes epilepsy, arteriovenous malformations, brain tumor, multiple sclerosis, aneurysms, and ischemic stroke.
Neurology Devices Market Trends, Drivers, Restraints, and Opportunities
- Rising research & development (R&D) expenditure in the field of neurotherapy is anticipated to propel the growth of the market.
- Growing investment by private players is expected to boost the market growth.
- Implementation of stringent government regulations toward the approval of neurology devices can hamper the market growth.
- Introduction of new products and innovations in neurology devices is estimated to provide lucrative opportunities for the market expansion.
Scope of the Neurology Devices Market Report
The report on the Netherlands neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Netherlands neurology devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Type Of Devices (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices [Interventional/Surgical Simulators, Neurothrombectomy Devices, Carotid Artery Stents, Embolic Coils, and Support Devices], Neurosurgery Devices [Neuroendoscopes, Stereotactic Systems, Aneurysm Clips, and Other Neurosurgery Devices], Neurostimulation Devices [Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Other Neurostimulation Devices], and Other Type of Devices)
|
|
Geographical Zone
|
The Netherlands
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
B.Braun Melsungen AG; Boston Scientific Corporation; Stryker Corporation; Medtronic PLC; and Abbott Laboratories
|
Netherlands Neurology Devices Market Segment Insights
Cerebrospinal Fluid Management Devices segment is anticipated to expand at a healthy CAGR
Based on type of devices, the market is divided into cerebrospinal fluid management devices, interventional neurology devices, neurosurgery devices, neurostimulation devices, and other type of devices. The interventional neurology devices segment is further segregated into interventional/surgical simulators, neurothrombectomy devices, carotid artery stents, embolic coils, and support devices.
Additionally, the neurosurgery devices segment is classified as neuroendoscopes, stereotactic systems, aneurysm clips, and other neurosurgery devices. The neurostimulation devices segment is sub-segmented into spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, and other neurostimulation devices.
The cerebrospinal fluid management devices segment is expected to grow at a rapid pace during the forecast period owing to usage of these devices for diagnosis of various neurological devices. However, the neurosurgery devices segment is anticipated to hold a key share of the market in the coming years on account of easy availability of neurological devices in hospital settings and preference among patients to visit hospitals for diagnosis and treatment of neurological devices.
Segments
The Netherlands neurology devices market has been segmented on the basis of
Types of devices
- Cerebrospinal Fluid Management Devices
- Interventional Neurology Devices
- Interventional/Surgical Simulators
- Neurothrombectomy Devices
- Carotid Artery Stents
- Embolic Coils
- Support Devices
- Neurosurgery Devices
- Neuroendoscopes
- Stereotactic Systems
- Aneurysm Clips
- Other Neurosurgery Devices
- Neurostimulation Devices
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Other Neurostimulation Devices
- Other Type of Devices
Country
Key Players
Competitive Landscape
Key players competing in the Netherlands neurology devices market are B. Braun Melsungen AG; Boston Scientific Corporation; Stryker Corporation; Medtronic PLC; and Abbott Laboratories.
In September 2021, Boston Scientific announced the completion of its acquisition of the Lumenis LTD., a privately-held global surgical business company, which develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA).
In September 2021, Medtronic PLC, the global leader in medical technology, announced a pilot program with Mpirik to address disparities in care associated with the prevention of sudden cardiac arrest (SCA), a condition in which the heart unexpectedly stops beating.
In July 2021, Stryker Corporation announced the acquisition of Gauss Surgical, a Menlo Park, California-based medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery.
Request For Customization
Enquiry Before Buying
Speak With Analyst
